Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.05B |
| 2 |
Texas Instruments
TXN
|
+$1.69B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Starbucks
SBUX
|
+$1.2B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$949M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.77B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.22B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.11B |
| 5 |
Procter & Gamble
PG
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Consumer Discretionary | 7.25% |
| 3 | Financials | 7.18% |
| 4 | Communication Services | 6.16% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NREF
3476
NexPoint Real Estate Finance
NREF
$342M
| $188K | ﹤0.01% |
13,728
+811
| +6% | +$11K |
|
3477
Jakks Pacific
JAKK
$293M
| $188K | ﹤0.01% |
10,511
-2,880
| -22% | -$56.8K |
|
|
CATC
3478
DELISTED
CAMBRIDGE BANCORP
CATC
| $188K | ﹤0.01% |
2,727
-4,049
| -60% | -$263K |
|
3479
Aveanna Healthcare
AVAH
$2.07B
| $188K | ﹤0.01% |
68,132
-17,507
| -20% | -$43.6K |
|
|
ZYXI
3480
DELISTED
Zynex
ZYXI
| $187K | ﹤0.01% |
20,108
-4,991
| -20% | -$53.1K |
|
3481
Century Casinos
CNTY
$34M
| $186K | ﹤0.01% |
67,264
-19,167
| -22% | -$55.6K |
|
3482
Riley Exploration Permian
REPX
$758M
| $186K | ﹤0.01% |
6,577
-925
| -12% | -$25.5K |
|
|
ZEUS
3483
DELISTED
Olympic Steel
ZEUS
| $186K | ﹤0.01% |
4,140
-5,256
| -56% | -$300K |
|
3484
iShares S&P 100 ETF
OEF
$20.6B
| $185K | ﹤0.01% |
700
| – | – |
|
3485
nLIGHT
LASR
$3.17B
| $185K | ﹤0.01% |
16,900
-23,369
| -58% | -$284K |
|
|
UBFO
3486
DELISTED
United Security Bancshares
UBFO
| $184K | ﹤0.01% |
25,405
| – | – |
|
3487
AdvisorShares Pure US Cannabis ETF
MSOS
$880M
| $184K | ﹤0.01% |
25,081
-6,300
| -20% | -$55K |
|
3488
Cooper-Standard Automotive
CPS
$558M
| $183K | ﹤0.01% |
14,729
-5,921
| -29% | -$84.9K |
|
|
STER
3489
DELISTED
Sterling Check Corp. Common Stock
STER
| $182K | ﹤0.01% |
12,293
-17,382
| -59% | -$267K |
|
|
UHT
3490
Universal Health Realty Income Trust
UHT
$594M
| $182K | ﹤0.01% |
4,644
-6,934
| -60% | -$253K |
|
3491
Daktronics
DAKT
$1.04B
| $182K | ﹤0.01% |
13,028
-13,734
| -51% | -$147K |
|
3492
Resources Connection
RGP
$145M
| $181K | ﹤0.01% |
16,401
-19,506
| -54% | -$219K |
|
3493
Acco Brands
ACCO
$407M
| $181K | ﹤0.01% |
38,489
-49,256
| -56% | -$246K |
|
|
ZIMV
3494
DELISTED
ZimVie
ZIMV
| $181K | ﹤0.01% |
9,908
-8,626
| -47% | -$141K |
|
|
GAUZ
3495
Gauzy
GAUZ
$8.13M
| $180K | ﹤0.01% |
+15,000
| New | +$200K |
|
3496
Sun Life Financial
SLF
$45.4B
| $179K | ﹤0.01% |
3,663
-30,852
| -89% | -$1.57M |
|
|
VIGL
3497
DELISTED
Vigil Neuroscience
VIGL
| $179K | ﹤0.01% |
44,755
-68,281
| -60% | -$234K |
|
|
SEVN
3498
Seven Hills Realty Trust
SEVN
$174M
| $179K | ﹤0.01% |
+14,100
| New | +$178K |
|
|
INST
3499
DELISTED
Instructure Holdings, Inc.
INST
| $179K | ﹤0.01% |
7,630
-6,130
| -45% | -$130K |
|
3500
Southern California Bancorp
BCAL
$682M
| $179K | ﹤0.01% |
+13,257
| New | +$184K |
|
Similar funds
Barclays's Q2 2024 Portfolio in Review
As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.
- Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
- Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
- Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
- Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
- Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
- Barclays opened 406 new positions and closed 646 in Q2 2024.
- Barclays's portfolio value rose 14% quarter-over-quarter to $327B.
Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.